AMDIPHARM UK LIMITED

04606340
Active London

Other business support service activities n.e.c.

0 employees website.com
Other business support service activities n.e.c.
A

AMDIPHARM UK LIMITED

04606340

Other business support service activities n.e.c.

Founded 2 Dec 2002 Active London, United Kingdom 0 employees website.com
Other business support service activities n.e.c.

Previous Company Names

AMDIPHARM LIMITED 1 Mar 2013 — 16 May 2013
AMDIPHARM PLC 2 Dec 2002 — 1 Mar 2013
Accounts Submitted 20 Oct 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 10 Dec 2025 Next due 2 Dec 2026 5 months remaining
Net assets £366K £0 2024 year on year
Total assets £366K £0 2024 year on year
Total Liabilities £0
Charges 6
6 satisfied

Contact & Details

Contact

Registered Address

Dashwood House 69 Old Broad Street London EC2M 1QS United Kingdom

Full company profile for AMDIPHARM UK LIMITED (04606340), an active company based in London, United Kingdom. Incorporated 2 Dec 2002. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type dormant
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£366.21k

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Mercury Pharma Group Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 15 Nov 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Concordia International Corporation

Ceased 27 Mar 2020

Ceased

The Blackstone Group Inc.

Ceased 1 Jun 2021

Ceased

Group Structure

Group Structure

AMDIPHARM UK LIMITED Current Company

Charges

Charges

6 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Dec 2025Confirmation StatementConfirmation statement made on 18 Nov 2025 with no updates
20 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
8 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
19 Feb 2025OfficersAppointment of Mr. Amaar Fainan Idris as director on 6 Feb 2025
19 Feb 2025OfficersTermination of Vikram Laxman Kamath as director on 6 Feb 2025
10 Dec 2025 Confirmation Statement

Confirmation statement made on 18 Nov 2025 with no updates

20 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

8 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

19 Feb 2025 Officers

Appointment of Mr. Amaar Fainan Idris as director on 6 Feb 2025

19 Feb 2025 Officers

Termination of Vikram Laxman Kamath as director on 6 Feb 2025

Recent Activity

Latest Activity

Confirmation statement made on 18 Nov 2025 with no updates

6 months ago on 10 Dec 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 20 Oct 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 8 Oct 2025

Appointment of Mr. Amaar Fainan Idris as director on 6 Feb 2025

1 years ago on 19 Feb 2025

Termination of Vikram Laxman Kamath as director on 6 Feb 2025

1 years ago on 19 Feb 2025